Latest From AmerisourceBergen Corp.
Teva and three distributors settle with two plaintiffs; PBMs are defendants in next case as Teva also reaches an agreement in principal with four attorneys general for global settlement framework.
Trial opens after settlement proposals by three distributors, Teva and J&J fail to gain support of cities and counties. Distributors want to call former FDA Commissioner Kessler to testify over plaintiffs' objections. Judge rules plaintiffs cannot seek future damages.
Investors may have more clarity on Teva's long-term outlook if the generic drug maker reaches a settlement in a big opioid case before it goes to trial in Ohio next week.
Four distributors and Walgreens also remain defendants; court to consider Teva's motion to dismiss if the trial results in a judgement against its subsidiaries. Seven-week trial could include 215 witnesses and 21,000 exhibits.
- Therapeutic Areas
- AmeriSource Health Corp.
- North America
- Parent & Subsidiaries
- Alco Health Distribution Corp.
- Archer Drug Co.
- Bellco Health Corp.
- Bergen Brunswig Corp.
- Bridge Medical Inc.
- LS DuBois Son & Co.
- Michiana Merchandising Systems Inc.
- Mississippi Drug Co. Inc.
- Walker Drug Co.
- Senior Management
Steven H Collis, Chmn., Pres. & CEO
Tim Guttman, CFO
John Chou, Chief Legal & Business Officer
- Contact Info
Phone: (610) 727-7000
P.O. Box 959 Valley Forge, PA 19482
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.